Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanisms

被引:124
作者
Pan, Xiaohua [1 ,2 ]
Fang, Xin [1 ,2 ,3 ]
Wang, Fei [4 ]
Li, Hongli [1 ,2 ]
Niu, Wenying [1 ,2 ,3 ]
Liang, Wenjie [1 ,2 ,3 ]
Wu, Chengfei [1 ,2 ]
Li, Jiahong [1 ,2 ]
Tu, Xing [1 ,2 ]
Pan, Li-Long [3 ]
Sun, Jia [1 ,2 ]
机构
[1] Jiangnan Univ, State Key Lab Food Sci Technol, 1800 Lihu Ave, Wuxi 214122, Jiangsu, Peoples R China
[2] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Jiangsu, Peoples R China
[3] Jiangnan Univ, Sch Med, 1800 Lihu Ave, Wuxi 214122, Jiangsu, Peoples R China
[4] Tongji Univ, Sch Med, Tongji Hosp, Div Gastroenterol & Hepatol,Digest Dis Inst, Shanghai, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
CHAIN FATTY-ACIDS; NLRP3 INFLAMMASOME ACTIVATION; METABOLITE BUTYRATE; CONCISE GUIDE; SIGNALING PATHWAY; RECEPTOR; BARRIER; STAT1; INHIBITION; RESPONSES;
D O I
10.1111/bph.14806
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Purpose Acute pancreatitis (AP) is a common acute abdominal condition, frequently associated with intestinal barrier dysfunction, which aggravates AP retroactively. Butyrate exhibits anti-inflammatory effects in a variety of inflammatory diseases. However, its potential beneficial effect on AP and the underlying mechanisms have not been investigated. Experimental Approach Experimental AP was induced by caerulein hyperstimulation in wild-type and GPR109A(-/-) mice. Sodium butyrate was administered intragastrically for 7 days prior to caerulein hyperstimulation. Anti-inflammatory mechanisms of butyrate were further investigated in peritoneal macrophages. Key Results Butyrate prophylaxis attenuated AP as shown by reduced serum amylase and lipase levels, pancreatic oedema, myeloperoxidase activity, and improved pancreatic morphology. Amelioration of pancreatic damage by butyrate was associated with reduced levels of TNF-alpha, IL-6, and CCL2 and suppressed activation of the NLRP3 inflammasome in both pancreas and colon. Further, butyrate ameliorated pancreatic inflammation by suppressing interactions between histone deacetylase 1 (HDAC1) and AP1 and STAT1 with increased histone acetylation at H3K9, H3K14, H3K18, and H3K27 loci, resulting in suppression of NLRP3 inflammasome activation and modulation of immune cell infiltration in pancreas. Additionally, butyrate mediated STAT1/AP1-NLRP3 inflammasome suppression via HDAC1 inhibition was demonstrated in peritoneal macrophage. In colon, butyrate inhibited NLRP3 inflammasome activation via GPR109A. Accordingly, the modulatory effects of butyrate on AP, AP-associated gut dysfunction, and NLRP3 inflammasome activation were diminished in GPR109A(-/-) mice. Conclusion and Implications Our study dissected tissue-specific anti-inflammatory mechanisms of butyrate during AP, suggesting that increased colonic levels of butyrate may be a strategy to protect against AP.
引用
收藏
页码:4446 / 4461
页数:16
相关论文
共 64 条
  • [1] THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview
    Alexander, Stephen P. H.
    Kelly, Eamonn
    Marrion, Neil V.
    Peters, John A.
    Faccenda, Elena
    Harding, Simon D.
    Pawson, Adam J.
    Sharman, Joanna L.
    Southan, Christopher
    Buneman, O. Peter
    Cidlowski, John A.
    Christopoulos, Arthur
    Davenport, Anthony P.
    Fabbro, Doriano
    Spedding, Michael
    Striessnig, Jorg
    Davies, Jamie A.
    Abbracchio, M. P.
    Aldrich, R.
    Al-Hosaini, K.
    Arumugam, T., V
    Attali, B.
    Back, M.
    Barnes, N. M.
    Bathgate, R.
    Beart, P. M.
    Becirovic, E.
    Bettler, B.
    Biel, M.
    Birdsall, N. J.
    Blaho, V
    Boison, D.
    Brauner-Osborne, H.
    Broer, S.
    Bryant, C.
    Burnstock, G.
    Calo, G.
    Catterall, W. A.
    Ceruti, S.
    Chan, S. L.
    Chandy, K. G.
    Chazot, P.
    Chiang, N.
    Chun, J. J.
    Chung, J. J.
    Clapham, D. E.
    Clapp, L.
    Connor, M. A.
    Cox, H. M.
    Davies, P.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 : S1 - S16
  • [2] Alexander SPH, 2017, BRIT J PHARMACOL, V174, pS272, DOI [10.1111/bph.13877, 10.1111/bph.13882]
  • [3] THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
    Alexander, Stephen P. H.
    Christopoulos, Arthur
    Davenport, Anthony P.
    Kelly, Eamonn
    Marrion, Neil V.
    Peters, John A.
    Faccenda, Elena
    Harding, Simon D.
    Pawson, Adam J.
    Sharman, Joanna L.
    Southan, Christopher
    Davies, Jamie A.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 : S17 - S129
  • [4] Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
    Alexander, Steve P. H.
    Roberts, Richard E.
    Broughton, Brad R. S.
    Sobey, Christopher G.
    George, Christopher H.
    Stanford, S. Clare
    Cirino, Giuseppe
    Docherty, James R.
    Giembycz, Mark A.
    Hoyer, Daniel
    Insel, Paul A.
    Izzo, Angelo A.
    Ji, Yong
    MacEwan, David J.
    Mangum, Jonathan
    Wonnacott, Sue
    Ahluwalia, Amrita
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (03) : 407 - 411
  • [5] Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
    Arpaia, Nicholas
    Campbell, Clarissa
    Fan, Xiying
    Dikiy, Stanislav
    van der Veeken, Joris
    deRoos, Paul
    Liu, Hui
    Cross, Justin R.
    Pfeffer, Klaus
    Coffer, Paul J.
    Rudensky, Alexander Y.
    [J]. NATURE, 2013, 504 (7480) : 451 - +
  • [6] Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
    Bauernfeind, Franz G.
    Horvath, Gabor
    Stutz, Andrea
    Alnemri, Emad S.
    MacDonald, Kelly
    Speert, David
    Fernandes-Alnemri, Teresa
    Wu, Jianghong
    Monks, Brian G.
    Fitzgerald, Katherine A.
    Hornung, Veit
    Latz, Eicke
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 183 (02) : 787 - 791
  • [7] The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
    Chang, Pamela V.
    Hao, Liming
    Offermanns, Stefan
    Medzhitov, Ruslan
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (06) : 2247 - 2252
  • [8] The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity
    Chen, Ping
    Huang, Liya
    Zhang, Yongping
    Qiao, Minmin
    Yao, Weiyan
    Yuan, Yaozong
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 27 (05) : 731 - 738
  • [9] Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3
    Chen, Shoubo
    Ye, Jingfang
    Chen, Xiangrong
    Shi, Jinnan
    Wu, Wenhua
    Lin, Wenping
    Lin, Weibin
    Li, Yasong
    Fu, Huangde
    Li, Shun
    [J]. JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [10] Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
    Curtis, Michael J.
    Alexander, Steve
    Cirino, Giuseppe
    Docherty, James R.
    George, Christopher H.
    Giembycz, Mark A.
    Hoyer, Daniel
    Insel, Paul A.
    Izzo, Angelo A.
    Ji, Yong
    MacEwan, David J.
    Sobey, Christopher G.
    Stanford, S. Clare
    Teixeira, Mauro M.
    Wonnacott, Sue
    Ahluwalia, Amrita
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (07) : 987 - 993